M42 appoints Dr Summia Zaher as CEO
Anjum Khan
M42, a leading healthtech company, has appointed Dr. Summia Zaher as the new Chief Executive Officer of Danat Al Emarat Hospital for Women & Children, effective immediately.
In her new role, Dr. Summia brings around 20 years of experience in the healthcare industry. She joined Danat Al Emarat Hospital in 2023 as the Medical Director and will continue to lead the healthcare firm’s growth and innovation across the GCC. In her previous roles, she worked as a Senior Lecturer at Cardiff University and as a Consultant Obstetrician and Obstetric Lead at the University Hospital of Wales.
On the academic front, Dr. Summia holds an MBBS degree from the University of Dundee, a Doctor of Medicine from Imperial College London, and a postgraduate degree in Clinical Leadership from the University of Wales Trinity Saint David. She also qualified for the MRCOG in Obstetrics & Gynaecology from the Royal College of Obstetricians & Gynaecologists.
Welcoming Dr. Summia to her new leadership role, Hasan Jasem Al Nowais, Managing Director and Group CEO of M42 and Chairman of Cleveland Clinic Abu Dhabi, said: “Dr. Summia’s leadership and expertise are invaluable to Danat Al Emarat Hospital for Women and Children’s mission to provide world-class care in the region. We are confident that under her leadership, the hospital will continue to set new standards in women’s healthcare and further cement its position as a leader.”
You may also like:
- CEO Khalid Albdah to exit Goldman Sachs KSA?
- Digital fatigue among employees opens door to Cyberattacks?
- Maan Fatani on role of HR in reshaping workforce, culture and business
- What does having women on the board really mean?
Dr. Summia added, “I am honoured to lead Danat Al Emarat Hospital for Women and Children as we continue to advance women’s healthcare in the UAE and the region. The all-female executive team at the hospital understands patients’ needs and is driving our focus, which is to continue providing exceptional care to every woman and child patient and to advance care at a national and regional level.”
